Quoin Pharmaceuticals Ltd. - 8-K Filing

Quoin Pharmaceuticals published a peer-reviewed paper on its investigational therapy QRX003, including positive results from a pediatric compassionate-use case report. (Items: 7.01 Regulation FD Disclosure, 8.01 Other Events, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $QNRX

Read the full article at SEC EDGAR

More Regulatory news